Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
197,9 USD | -1,64 % | -7,01 % | -12,81 % |
Resumen de negocios
- servicios de laboratorio clínico (63,9%): pruebas de rutina, diagnóstico de pacientes, seguimiento y tratamiento de enfermedades y otros servicios;
- servicios de desarrollo y ensayos clínicos (36,1%): para empresas farmacéuticas, biotecnológicas, de dispositivos médicos y de diagnóstico.
Las ventas netas se distribuyen geográficamente de la siguiente manera : América del Norte (81,2%), Europa (12,7%) y otros (6,1%).
Número de empleados: 61 975
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Diagnostics Laboratories
77,4
%
| 9 204 | 61,9 % | 9 415 | 77,4 % | +2,30 % |
Biopharma Laboratory Services
22,8
%
| 5 710 | 38,4 % | 2 774 | 22,8 % | -51,42 % |
Intercompany Eliminations and Other
-0,2
%
| -37 | -0,2 % | -28 | -0,2 % | -24,93 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
83,7
%
| 11 531 | 77,5 % | 10 178 | 83,7 % | -11,73 % |
Europe
9,0
%
| 1 934 | 13,0 % | 1 095 | 9,0 % | -43,40 % |
Other
4,0
%
| 1 041 | 7,0 % | 486 | 4,0 % | -53,29 % |
North America
3,3
%
| 371 | 2,5 % | 403 | 3,3 % | +8,61 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 58 | 01/04/13 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 63 | 16/06/14 |
Compliance Officer | 65 | 01/02/19 | |
Mark Schroeder
COO | Chief Operating Officer | 63 | 01/05/07 |
Lance Berberian
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/02/14 |
Brian Caveney
CTO | Chief Tech/Sci/R&D Officer | 50 | 25/09/17 |
Chief Tech/Sci/R&D Officer | - | - | |
Henry Dong
PRN | Corporate Officer/Principal | - | - |
George Maha
PRN | Corporate Officer/Principal | - | - |
Earle Collum
PRN | Corporate Officer/Principal | - | - |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 58 | 01/04/13 |
Peter Neupert
BRD | Director/Board Member | 68 | 01/01/13 |
Kerrii Anderson
BRD | Director/Board Member | 66 | 17/05/06 |
Jeffrey Davis
BRD | Director/Board Member | 61 | 01/12/19 |
Paul Rothman
BRD | Director/Board Member | 66 | 06/06/23 |
Garheng Kong
BRD | Director/Board Member | 49 | 01/12/13 |
Richelle Parham
BRD | Director/Board Member | 56 | 08/02/16 |
D. Gilliland
BRD | Director/Board Member | 69 | 01/04/14 |
Kathryn Wengel
BRD | Director/Board Member | 58 | 25/03/21 |
Director/Board Member | 57 | 12/10/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 84 293 628 | 84 000 632 ( 99,65 %) | 0 | 99,65 % |
Información de la empresa
Laboratory Corp. of America Holdings
358 South Main Street
27215-5837, Burlington
+336 229 1127
http://www.labcorp.comEmpresas del grupo
Nombre | Categoría y sector |
---|---|
Miscellaneous Commercial Services
| |
Labcorp Early Development Laboratories Ltd.
Labcorp Early Development Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Labcorp Early Development Laboratories Ltd. is a British company that provides early-stage and late-stage product development services. The company is based in Harrogate, UK. Labcorp Early Development Laboratories was founded in 1974. |
Miscellaneous Commercial Services
|
Fortrea Development Ltd.
Fortrea Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Fortrea Development Ltd. is a British company that provides clinical development services. The company is based in Maidenhead, UK. |
Miscellaneous Commercial Services
|
Labcorp International Holdings BV
| |
Pharmaceuticals: Major
| |
Chiltern International Ltd.
Chiltern International Ltd. Miscellaneous Commercial ServicesCommercial Services Chiltern International, Inc. provides clinical research services. It offers clinical development, medical and scientific affairs, data and analysis, pharmacovigilance and strategic regulatory services. The firm serves biotech, pharmaceuticals, biosimilars and biologics and medical device and diagnostics industries. The company was founded in 1982 and is headquartered in Slough, the United Kingdom. |
Miscellaneous Commercial Services
|
Dynacare-Gamma Laboratory Partnership
Dynacare-Gamma Laboratory Partnership Medical/Nursing ServicesHealth Services Gamma-Dynacare Medical Laboratories Inc, Providing Information, Impacting Lives, Caring for People. By living this mission, Gamma-Dynacare Medical Laboratories will achieve its vision of becoming the trusted leader in transforming laboratory information and services into solutions that improve health, wellness and the Canadian health care system. Gamma-Dynacare is one of Canada's largest and most respected providers of laboratory services and solutions, with more than 50 years of experience serving Canadians. Each day, they support tens of thousands of patients, healthcare professionals and public and private sector clients with the efficient collection and transportation of specimens, accurate testing in their state-of-the-art laboratories and prompt reporting of results. |
Medical/Nursing Services
|
Clearstone Holdings (International) Ltd.
Clearstone Holdings (International) Ltd. Financial ConglomeratesFinance Part of Laboratory Corp. of America Holdings, Clearstone Holdings (International) Ltd. functions as an investment holding British company. The company is based in London, UK. |
Financial Conglomerates
|
Labcorp International Holdings Ltd.
Labcorp International Holdings Ltd. Financial ConglomeratesFinance Chiltern International Holdings Ltd. operates as an investment holding firm. The company was founded on January 12, 1996 and is headquartered in Maidenhead, the United Kingdom. |
Financial Conglomerates
|
Sector
Ventas por actividad
Ventas por región
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
-12,81 % | 16,96 mil M | |
+15,87 % | 83,4 mil M | |
-27,66 % | 72,11 mil M | |
0,00 % | 27,04 mil M | |
+1,03 % | 16,86 mil M | |
+2,52 % | 15,76 mil M | |
+70,51 % | 13,33 mil M | |
+1,50 % | 12,76 mil M | |
+70,44 % | 12,74 mil M | |
+1,11 % | 12,32 mil M |
- Bolsa de valores
- Acciones
- Acción LH
- Empresa Labcorp Holdings Inc.